Applied Biological Chemistry

, Volume 59, Issue 2, pp 259–269 | Cite as

Myricetin: biological activity related to human health

  • Kwang-Su Park
  • Youhoon ChongEmail author
  • Mi Kyoung KimEmail author


Myricetin (3,5,7,3′,4′,5′-hexahydroxyflavone) is one of the natural flavonols from fruit, vegetable, tea, and medicinal plants. A great deal of attention has been paid to this compound owing to its various health-promoting effects. In this review, we provide a comprehensive discussion of the therapeutic potential of myricetin by focusing on its biological activity and pharmacokinetic properties.


Biological activity Health-promoting effect Myricetin Pharmacokinetics 



This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2006455) and by a Grant from the Priority Research Centers Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2009-0093824).


  1. Awad HM, Boersma MG, Vervoort J, Rietjens IMCM (2000) Peroxidase-catalyzed formation of quercetin quinone methide–glutathione adducts. Arch Biochem Biophys 378:224–233CrossRefGoogle Scholar
  2. Bai HW, Zhu BT (2010) Myricetin and quercetin are naturally occurring co-substrates of cyclooxygenase in vivo. Prostaglandins Leukot Essent 82:45–50CrossRefGoogle Scholar
  3. Bartolini M, Naldi M, Fiori J, Valle F, Biscarini F, Nicolau DV, Andrisano V (2011) Kinetic characterization of amyloid-beta 1-42 aggregation with a multimethodological approach. Anal Biochem 414:215–225CrossRefGoogle Scholar
  4. Berhanu WM, Masunov AE (2015) Atomistic mechanism of polyphenol amyloid aggregation inhibitors: molecular dynamics study of curcumin, exifone, and myricetin interaction with the segment of tau peptide oligomer. J Biomol Struct Dyn 33:1399–1411CrossRefGoogle Scholar
  5. Boots AW, Haenen GR, Bast A (2008) Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 585:325–327CrossRefGoogle Scholar
  6. Buchter C, Ackermann D, Havermann S, Honnen S, Chovolou Y, Fritz G, Watjen W (2013) Myricetin-mediated lifespan extension in Caenorhabditis elegans is modulated by DAF-16. Int J Mol Sci 14:11895–11914CrossRefGoogle Scholar
  7. Chang CJ, Tzeng TF, Liou SS, Chang YS, Liu IM (2012) Myricetin increases hepatic peroxisome proliferator-activated receptor alpha protein expression and decreases plasma lipids and adiposity in rats. Evid Based Complement Alternat Med 2012:787152Google Scholar
  8. Cheng X, Siow RC, Mann GE (2011) Impaired redox signaling and antioxidant gene expression in endothelial cells in diabetes: a role for mitochondria and the nuclear factor-E2-related factor 2-Kelch-like ECH-associated protein 1 defense pathway. Antioxid Redox Signal 14:469–487CrossRefGoogle Scholar
  9. Chobot V, Hadacek F (2011) Exploration of pro-oxidant and antioxidant activities of the flavonoid myricetin. Redox Rep 16:242–247CrossRefGoogle Scholar
  10. Choi DH, Li C, Choi JS (2010) Effects of myricetin, an antioxidant, on the pharmacokinetics of losartan and its active metabolite, EXP-3174, in rats: possible role of cytochrome P450 3A4, cytochrome P450 2C9 and P-glycoprotein inhibition by myricetin. J Pharm Pharmacol 62:908–914CrossRefGoogle Scholar
  11. Choi HN, Kang MJ, Lee SJ, Kim JI (2014a) Ameliorative effect of myricetin on insulin resistance in mice fed a high-fat, high-sucrose diet. Nutr Res Pract 8:544–549CrossRefGoogle Scholar
  12. Choi SM, Kim BC, Cho YH, Choi KH, Chang J, Park MS, Kim JK (2014b) Effects of flavonoid compounds on β-amyloid-peptide-induced neuronal death in cultured mouse cortical neurons. Chonnam Med J 50:45–51CrossRefGoogle Scholar
  13. Dang Y, Lin G, Xie Y, Duan J, Ma P, Li G, Ji G (2014) Quantitative determination of myricetin in rat plasma by ultraperformance liquid chromatography tandem mass spectrometry and its absolute bioavailability. Drug Res (Stuttg) 64:516–522Google Scholar
  14. Ding Y, Zhang ZF, Dai XQ, Li Y (2012) Myricetin protects against cytokine-induced cell death in RIN-m5f beta cells. J Med Food 15:733–740CrossRefGoogle Scholar
  15. Duthie G, Morrice P (2012) Antioxidant capacity of flavonoids in hepatic microsomes is not reflected by antioxidant effects in vivo. Oxid Med Cell Longev 2012:165127CrossRefGoogle Scholar
  16. Fraga CG, Martino VS, Ferraro GE, Coussio JD, Boveris A (1987) Flavonoids as antioxidants evaluated by in vitro and in situ liver chemiluminescence. Biochem Pharmacol 36:717–720CrossRefGoogle Scholar
  17. Franco JL, Posser T, Missau F, Pizzolatti MG, Dos Santos AR, Souza DO, Farina M (2010) Structure-activity relationship of flavonoids derived from medicinal plants in preventing methylmercury-induced mitochondrial dysfunction. Environ Toxicol Pharmacol 30:272–278CrossRefGoogle Scholar
  18. Furumiya M, Inoue K, Nishijima C, Yamashiro T, Inaoka E, Ohta K, Yuasa H (2014) Noncompetitive inhibition of proton-coupled folate transporter by myricetin. Drug Metab Pharmacokinet 29:312–316CrossRefGoogle Scholar
  19. Furuno K, Akasako T, Sugihara N (2002) The contribution of the pyrogallol moiety to the superoxide radical scavenging activity of flavonoids. Biol Pharm Bull 25:19–23CrossRefGoogle Scholar
  20. Fusi F, Saponara S, Frosini M, Gorelli B, Sgaragli G (2003) L-type Ca2+ channels activation and contraction elicited by myricetin on vascular smooth muscles. Naunyn Schmiedebergs Arch Pharmacol 368:470–478CrossRefGoogle Scholar
  21. Fusi F, Sgaragli G, Saponara S (2005) Mechanism of myricetin stimulation of vascular L-type Ca2+ current. J Pharmacol Exp Ther 313:790–797CrossRefGoogle Scholar
  22. Ghidouche S, Es-Safi NE, Ducrot PH (2007) Trtametes versicolor laccase mediated oxidation of flavonoids. influence of the hydroxylation pattern of ring B of flavonols. Am J Food Technol 2:630–640CrossRefGoogle Scholar
  23. Gordon MH, Roedig-Penmanm A (1998) Antioxidant activity of quercetin and myricetin in liposomes. Chem Phys Lipids 97:79–85CrossRefGoogle Scholar
  24. Griep MA, Blood S, Larson MA, Koepsell SA, Hinrichs SH (2007) Myricetin inhibits Escherichia coli DnaB helicase but not primase. Bioorg Med Chem 15:7203–7208CrossRefGoogle Scholar
  25. Hagenacker T, Hillebrand I, Wissmann A, Busselberg D, Schafers M (2010) Anti-allodynic effect of the flavonoid myricetin in a rat model of neuropathic pain: involvement of p38 and protein kinase C mediated modulation of Ca2+ channels. Eur J Pain 14:992–998CrossRefGoogle Scholar
  26. Halliwell B (1978) Superoxide-dependant formation of hydroxyl radicals in the presence of iron chelates: is it a mechanism for hydroxyl radical production in biological systems? FEBS Lett 92:321–326CrossRefGoogle Scholar
  27. Hamaguchi T, Ono K, Murase A, Yamada M (2009) Phenolic compounds prevent Alzheimer’s pathology through different effects on the amyloid-beta aggregation pathway. Am J Pathol 175:2557–2565CrossRefGoogle Scholar
  28. Henneberg R, Otuki MF, Furman AE, Hermann P, do Nascimento AJ, Leonart MS (2013) Protective effect of flavonoids against reactive oxygen species production in sickle cell anemia patients treated with hydroxyurea. Rev Bras Hematol Hemoter 35:52–55Google Scholar
  29. Hirohata M, Hasegawa K, Tsutsumi-Yasuhara S, Ohhashi Y, Ookoshi T, Ono K, Naiki H (2007) The anti-amyloidogenic effect is exerted against Alzheimer’s beta-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure. Biochemistry 46:1888–1899CrossRefGoogle Scholar
  30. Holder S, Zemskova M, Zhang C, Tabrizizad M, Bremer R, Neidigh JW, Lilly MB (2007) Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinase. Mol Cancer Ther 6:163–172CrossRefGoogle Scholar
  31. Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444:860–867CrossRefGoogle Scholar
  32. Hussain SR, Cillard J, Cillard P (1987) Hydroxyl radical scavenging activity of flavonoids. Phytochemistry 26:2489–2491CrossRefGoogle Scholar
  33. Jayakumar JK, Nirmala P, Praveen Kumar BA, Kumar AP (2014) Evaluation of protective effect of myricetin, a bioflavonoid in dimethyl benzanthracene-induced breast cancer in female Wistar rats. South Asian J Cancer 3:107–111CrossRefGoogle Scholar
  34. Kang BY, Kim SH, Cho D, Kim TS (2005) Inhibition of interleukin-12 production in mouse macrophages via decreased nuclear factor-kappaB DNA binding activity by myricetin, a naturally occurring flavonoid. Arch Pharm Res 28:274–279CrossRefGoogle Scholar
  35. Kang KA, Wang ZH, Zhang R, Piao MJ, Kim KC, Kang SS, Hyun JW (2010) Myricetin protects cells against oxidative stress-induced apoptosis via regulation of PI3 K/Akt and MAPK signaling pathways. Int J Mol Sci 11:4348–4360CrossRefGoogle Scholar
  36. Keshet B, Gray JJ, Good TA (2010) Structurally distinct toxicity inhibitors bind at common loci on beta-amyloid fibril. Protein Sci 19:2291–2304CrossRefGoogle Scholar
  37. Khanduja KL, Bhardwaj A (2003) Stable free radical scavenging and antiperoxidative properties of resveratrol compared in vitro with some other bioflavonoids. Indian J Biochem Biophys 40:416–422Google Scholar
  38. Kim JE, Kwon JY, Lee DE, Kang NJ, Heo YS, Lee KW, Lee HJ (2009) MKK4 is a novel target for the inhibition of tumor necrosis factor-alpha-induced vascular endothelial growth factor expression by myricetin. Biochem Pharmacol 77:412–421CrossRefGoogle Scholar
  39. Ko CH, Shen SC, Lee TJ, Chen YC (2005) Myricetin inhibits matrix metalloproteinase 2 protein expression and enzyme activity in colorectal carcinoma cells. Mol Cancer Ther 4:281–290Google Scholar
  40. Koren J, Jinwal UK, Jin Y, O’Leary J, Jones JR, Johnson AG, Dickey CA (2010) Facilitating Akt clearance via manipulation of Hsp70 activity and levels. J Biol Chem 285:2498–2505CrossRefGoogle Scholar
  41. Labbé D, Provencal M, Lamy S, Boivin D, Gingras D, Beliveau R (2009) The flavonols quercetin, kaempferol, and myricetin inhibit hepatocyte growth factor-induced medulloblastoma cell migration. J Nutr 139:646–652CrossRefGoogle Scholar
  42. Lee YS, Choi EM (2010) Myricetin inhibits IL-1 beta-induced inflammatory mediators in SW982 human synovial sarcoma cells. Int Immunopharmacol 10:812–814CrossRefGoogle Scholar
  43. Li Y, Ding Y (2012) Minireview: therapeutic potential of myricetin in diabetes mellitus. Food Sci Human Well 1:19–25CrossRefGoogle Scholar
  44. Li C, Lim SC, Kim J, Choi JS (2011) Effects of myricetin, an anticancer compound, on the bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats. Eur J Drug Metab Pharmacokinet 36:175–182CrossRefGoogle Scholar
  45. Lin HH, Huang CY (2012) Characterization of flavonol inhibition of DnaB helicase: real-time monitoring, structural modeling, and proposed mechanism. J Biomed Biotechnol 2012:735368Google Scholar
  46. Liu IM, Liou SS, Lan TW, Hsu FL, Cheng JT (2005) Myricetin as the active principle of Abelmoschus moschatus to lower plasma glucose in streptozotocin-induced diabetic rats. Planta Med 71:617–621CrossRefGoogle Scholar
  47. Lu J, Papp LV, Fang J, Rodriguez-Nieto S, Zhivotovsky B, Holmgren A (2006) Inhibition of mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity. Cancer Res 66:4410–4418CrossRefGoogle Scholar
  48. McCord JM, Day ED (1978) Superoxide-dependant production of hydroxyl radical catalyzed by iron-EDTA complex. FEBS Lett 86:139–142CrossRefGoogle Scholar
  49. Mendes V, Vilaca R, Freitas V, Ferreira PM, Mateus N, Costa V (2015) Effect of myricetin, pyrogallol, and phloroglucinol on yeast resistance to oxidative stress. Oxid Med Cell Longev 2015:782504CrossRefGoogle Scholar
  50. Metodiewa D, Jaiswal AK, Cenas N, Dickancaité E, Segura-Aguilar J (1999) Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. Free Radical Biol Med 26:107–116CrossRefGoogle Scholar
  51. Mukhtar H, Das M, Khan WA, Wang ZY, Bik DP, Bickers DR (1988) Exceptional activity of tannic acid among naturally occurring plant phenols in protecting against 7,12-dimethylbenz(a)anthracene-, benzo(a)pyrene-, 3-methylcholanthrene-, and N-methyl-N-nitrosourea-induced skin tumorigenesis in mice. Cancer Res 48:2361–2365Google Scholar
  52. Necula M, Kayed R, Milton S, Glabe CG (2007) Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. J Biol Chem 282:10311–10324CrossRefGoogle Scholar
  53. Ong KC, Khoo HE (1997) Biological effects of myricetin. Gen Pharmacol 29:121–126CrossRefGoogle Scholar
  54. Ong KC, Khoo HE (2000) Effects of myricetin on glycemia and glycogen metabolism in diabetic rats. Life Sci 67:1695–1705CrossRefGoogle Scholar
  55. Ono K, Nakane H, Fukushima M, Chermann JC, Barre-Sinoussi F (1990) Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases. Eur J Biochem 190:469–476CrossRefGoogle Scholar
  56. Ono K, Li L, Takamura Y, Yoshiike Y, Zhu L, Han F, Yamada M (2012) Phenolic compounds prevent amyloid beta-protein oligomerization and synaptic dysfunction by site-specific binding. J Biol Chem 287:14631–14643CrossRefGoogle Scholar
  57. Oyama Y, Fuchs PA, Katayama N, Noda K (1994) Myricetin and quercetin, the flavonoid constituents of Ginkgo biloba extract, greatly reduce oxidative metabolism in both resting and Ca(2 +)-loaded brain neurons. Brain Res 635:125–129CrossRefGoogle Scholar
  58. Pandey KB, Mishra N, Rizvi SI (2009) Myricetin may provide protection against oxidative stress in type 2 diabetic erythrocytes. Z Naturforsch C 64:626–630CrossRefGoogle Scholar
  59. Pasetto S, Pardi V, Murata RM (2014) Anti-HIV-1 activity of flavonoid myricetin on HIV-1 infection in a dual-chamber in vitro model. Plos One 9:e115323CrossRefGoogle Scholar
  60. Phillips PA, Sangwan V, Borja-Cacho D, Dudeja V, Vickers SM, Saluja AK (2011) Myricetin induces pancreatic cancer cell death via the induction of apoptosis and inhibition of the phosphatidylinositol 3-kinase (PI3 K) signaling pathway. Cancer Lett 308:181–188CrossRefGoogle Scholar
  61. Robak J, Gryglewski RJ (1988) Flavonoids are scavengers of superoxide anions. Biochem Pharmacol 37:837–841CrossRefGoogle Scholar
  62. Saponara S, Carosati E, Mugnai P, Sgaragli G, Fusi F (2011) The flavonoid scaffold as a template for the design of modulators of the vascular Ca(v) 1.2 channels. Br J Pharmacol 164:1684–1697CrossRefGoogle Scholar
  63. Sato M, Murakami K, Uno M, Nakagawa Y, Katayama S, Akagi K, Irie K (2013) Site-specific inhibitory mechanism for amyloid β42 aggregation by catechol-type flavonoids targeting the Lys residues. J Biol Chem 288:23212–23224CrossRefGoogle Scholar
  64. Shimmyo Y, Kihara T, Akaike A, Niidome T, Sugimoto H (2008a) Flavonols and flavones as BACE-1 inhibitors: structure-activity relationship in cell-free, cell-based and in silico studies reveal novel pharmacophore features. Biochim Biophys Acta 1780:819–825CrossRefGoogle Scholar
  65. Shimmyo Y, Kihara T, Akaike A, Niidome T, Sugimoto H (2008b) Multifunction of myricetin on Aβ: neuroprotection via a conformational change of Aβ and reduction of Aβ via the interference of secretases. J Neurosci Res 86:368–377CrossRefGoogle Scholar
  66. Strobel P, Allard C, Perez-Acle T, Calderon R, Aldunate R, Leighton F (2005) Myricetin, quercetin and catechin-gallate inhibit glucose uptake in isolated rat adipocytes. Biochem J 386:471–478CrossRefGoogle Scholar
  67. Sultana B, Anwar F (2008) Flavonols (kaempeferol, quercetin, myricetin) contents of selected fruits, vegetables and medicinal plants. Food Chem 108:879–884CrossRefGoogle Scholar
  68. Sun H, Niisato N, Nishio K, Hamilton KL, Marunaka Y (2014) Distinct action of flavonoids, myricetin and quercetin, on epithelial Cl secretion: useful tools as regulators of Cl secretion. Biomed Res Int 2014:902735Google Scholar
  69. Taniguchi S, Suzuki N, Masuda M, Hisanaga S, Iwatsubo T, Goedert M, Hasegawa M (2005) Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins. J Biol Chem 280:7614–7623CrossRefGoogle Scholar
  70. Tsai SH, Liang YC, Lin-Shiau SY, Lin JK (1999) Suppression of TNF alpha-mediated NF-kappaB activity by myricetin and other flavonoids through downregulating the activity of IKK in ECV304 cells. J Cell Biochem 74:606–615CrossRefGoogle Scholar
  71. Tzeng TF, Liou SS, Liu IM (2011) Myricetin ameliorates defective post-receptor insulin signaling via β-endorphin signaling in the skeletal muscles of fructose-fed rats. Evid Based Complement Alternat Med 2011:150752CrossRefGoogle Scholar
  72. US Department of Agriculture. (2003) USDA database for the flavonoid content of selected foods. Beltsville (MD): US Department of AgricultureGoogle Scholar
  73. Wang P, Bai HW, Zhu BT (2010a) Structural basis for certain naturally occurring bioflavonoids to function as reducing co-substrates of cyclooxygenase I and II. Plos One 5:e12316CrossRefGoogle Scholar
  74. Wang SJ, Tong Y, Lu S, Yang R, Liao X, Xu YF, Li X (2010b) Anti-inflammatory activity of myricetin isolated from Myrica rubra Sieb. et Zucc. leaves. Planta Med 76:1492–1496CrossRefGoogle Scholar
  75. Wang L, Feng J, Chen X, Guo W, Du Y, Wang Y, Zhao G (2014) Myricetin enhance chemosensitivity of 5-fluorouracil on esophageal carcinoma in vitro and in vivo. Cancer Cell Int 14:71–78CrossRefGoogle Scholar
  76. Xu HX, Lee SF (2001) Activity of plant flavonoids against antibiotic-resistant bacteria. Phytother Res 15:39–43CrossRefGoogle Scholar
  77. Xu H, Ziegelin G, Schroder W, Frank J, Ayora S, Alonso JC, Saenger W (2001) Flavones inhibit the hexameric replicative helicase RepA. Nucleic Acids Res 29:5058–5066CrossRefGoogle Scholar
  78. Xue CF, Guo JM, Qian DW, Duan JA, Shu Y (2011) Absorption of flavonoids from Abelmoschus manihot extract by in situ intestinal perfusion. Yao Xue Xue Bao 46:454–459Google Scholar
  79. Yamada K, Shoji K, Mori M, Ueyama T, Matsuo N, Oka S, Nishiyama K, Sugano M (1999) Structure-activity relationship of polyphenols on inhibition of chemical mediator release from rat peritoneal exudate cells. In Vitro Cell Dev Biol Anim 35:169–174CrossRefGoogle Scholar
  80. Yang Y, Shin JY, Oh JM, Jung CH, Hwang Y, Kim S, Kweon DH (2010) Dissection of SNARE-driven membrane fusion and neuroexocytosis by wedging small hydrophobic molecules into the SNARE zipper. Proc Natl Acad Sci 107:22145–22150CrossRefGoogle Scholar
  81. Yao Y, Lin G, Xie Y, Ma P, Li G, Meng Q, Wu T (2014) Preformulation studies of myricetin: a natural antioxidant flavonoid. Pharmazie 69:19–26Google Scholar
  82. Yee S (1997) In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man–fact or myth. Pharm Res 14:763–766CrossRefGoogle Scholar
  83. Yi L, Jin X, Chen CY, Fu YJ, Zhang T, Chang H, Mi MT (2011) Chemical structures of 4-oxo-flavonoids in relation to inhibition of oxidized low-density lipoprotein (LDL)-induced vascular endothelial dysfunction. Int J Mol Sci 12:5471–5489CrossRefGoogle Scholar
  84. Yuan CH, Filippova M, Tungteakkhun SS, Duerksen-Hughes PJ, Krstenansky JL (2012) Small molecule inhibitors of the HPV16-E6 interaction with caspase 8. Bioorg Med Chem Lett 22:2125–2129CrossRefGoogle Scholar
  85. Zamora-Ros R, Forouhi NG, Sharp SJ, Gonzalez CA, Buijsse B, Guevara M, Wareham NJ (2014) Dietary intakes of individual flavanols and flavonols are inversely associated with incident type 2 diabetes in European populations. J Nutr 144:335–343CrossRefGoogle Scholar
  86. Zelus C, Fox A, Calciano A, Faridian BS, Nogaj LA, Moffet DA (2012) Myricetin inhibits islet amyloid polypeptide (IAPP) aggregation and rescues living mammalian cells from IAPP toxicity. Open Biochem J 6:66–70CrossRefGoogle Scholar
  87. Zhang XH, Zou ZQ, Xu CW, Shen YZ, Li D (2011) Myricetin induces G2/M phase arrest in HepG2 cells by inhibiting the activity of the cyclin B/Cdc2 complex. Mol Med Rep 4:273–277Google Scholar
  88. Zhang XH, Ma ZG, Rowlands DK, Gou YL, Fok KL, Wong HY, Chan HC (2012) Flavonoid myricetin modulates GABAA receptor activity through activation of Ca2+ channels and CaMK-II pathway. Evid Based Complement Alternat Med 2012:758097Google Scholar
  89. Zhang S, Wang L, Liu H, Zhao G, Ming L (2014) Enhancement of recombinant myricetin on the radiosensitivity of lung cancer A549 and H1299 cells. Diagn Pathol 9:68–75CrossRefGoogle Scholar
  90. Zhao J, Hong T, Dong M, Meng Y, Mu J (2013) Protective effect of myricetin in dextran sulphate sodium-induced murine ulcerative colitis. Mol Med Rep 7:565–570Google Scholar
  91. Zou D, Liu P, Chen K, Xie Q, Liang X, Bai Q, Mi M (2015) Protective effects of myricetin on acute hypoxia-induced exercise intolerance and mitochondrial impairments in rats. Plos One 10:e0124727CrossRefGoogle Scholar

Copyright information

© The Korean Society for Applied Biological Chemistry 2016

Authors and Affiliations

  1. 1.Department of Bioscience & Biotechnology, Bio/Molecular Informatics CenterKonkuk UniversitySeoulRepublic of Korea

Personalised recommendations